An interventional study of S-Press in Deconditioning and Sarcopenia, sponsored by Sheffield Hallam University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-19.
Sponsored by Sheffield Hallam University · Not applicable, Interventional, and Treatment
The proposed study will examine the use and effectiveness of a novel strength training device - The S-Press within an NHS environment. The S-Press is a portable exercise device that can be used seated or lying down and specifically targets the knee extensors and flexors. The knee extensors are particularly important in the performance of activities of daily living such as rising from a chair, walking up and down stairs and walking.
Resistance training is the most effective strategy to help to reduce muscle wasting in response to ageing or chronic disuse; however as current in-patient settings likely fail to produce an overload stimulus to the muscle for hypertrophy and strength gains, there is a need to develop new interventions and equipment to help deliver this. The S-Press is designed by a Physiotherapist with the goal of increasing muscle strength and improving physical function in patients who may be confined to their bed or chair or unable to join in with standard physiotherapy treatments.
This mixed methods study will examine the efficacy of the S-Press to improve muscle size using B-Mode Ultrasound and physical function, using sit to stand x5 with use over 6 weeks, alongside the qualitative experience of the use of the S-Press through a one to one semi structured interview.
1,242 studies on the registry are indexed under Sarcopenia; 405 are open to participants now.
This study's enrollment of 9 is below the median of 60 across 793 interventional studies indexed under Sarcopenia.
Browse Sarcopenia studies →Sheffield Hallam University is the lead sponsor of 48 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Any patient who is unable to give informed consent.
Use of the S-Press during in patient stay alongside usual physiotherapy sessions
Device: S-Press
Leg Strengthening Device that can be used in supine and seated positions
Feasbility of use of S-Press by patients
30 minute Semi Structured Interview
Time frame: through study completion, an average of 2 weeks
Feasbility of use of S-Press by Healthcare Professionals
30 minute Semi Structured Interview
Time frame: through study completion, an average of 2 weeks
5x Sit to Stand time
time to complete 5 sit to stands from standardised chair
Time frame: through study completion, an average of 2 weeks
Muscle thickness
Ultrasound measurement of Vastus Lateralis
Time frame: through study completion, an average of 2 weeks
Heart rate during use
During exercise sessions
Time frame: through study completion, an average of 2 weeks
Systolic Blood Pressure during use
During exercise sessions
Time frame: through study completion, an average of 2 weeks
Diastolic Blood Pressure during use
During exercise sessions
Time frame: through study completion, an average of 2 weeks
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — Individual data are available on request
Ran from Apr 2021 to primary completion in Jan 2023, 21 months.
Of 474 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's 21 months is above that.
Counting every sponsor, half of 485 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheffield Hallam University